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The purpose of this study was to develop a method enabling synthetic computed tomography (sCT) generation 
of the whole abdomen using magnetic resonance imaging (MRI) images of pediatric patients with abdominal 
tumors. The proposed method relies on an automatic atlas-based segmentation of bone and lungs followed by an 
MRI intensity to synthetic Hounsfield unit conversion. Separate conversion algorithms were used for bone, 
lungs and soft-tissue. Rigidly registered CT and T2-weighted MR images of 30 patients in treatment position 
and with the same field of view were used for the evaluation of the atlas and the conversion algorithms. The 
dose calculation accuracy of the generated sCTs was verified for volumetric modulated arc therapy (VMAT) 
and pencil beam scanning (PBS). VMAT and PBS plans were robust optimized on an internal target volume 
(ITV) against a patient set-up uncertainty of 5 mm. Average differences between CT and sCT dose calculations 
for the ITV V95% were 0.5% (min 0.0%; max 5.0%) and 0.0% (min -0.1%; max 0.1%) for VMAT and PBS dose 
distributions, respectively. Average differences for the mean dose to the organs at risk were <0.2% (min -0.6%; 
max 1.2%) and <0.2% (min -2.0%; max 2.6%) for VMAT and PBS dose distributions, respectively. Results 
show that MRI-only photon and proton dose calculations are feasible for children with abdominal tumors. 
Keywords: magnetic resonance imaging, MRI-only treatment planning, pediatric IGRT, abdominal cancer, 
synthetic CT, proton therapy, photon therapy. 
1. Introduction 
 
Wilms’ tumor (WT) and neuroblastoma (NBL) belong to the most frequent abdominal tumors in pediatric 
patients. By combining the use of surgery, chemotherapy and radiotherapy, the survival rates for these patients 
have increased over the past few decades up to 90% for WT and 60% for NBL (Pritchard-Jones et al 2015, 
Ladenstein et al 2017).  
During radiotherapy treatment planning (RTP) with either photons or protons, computed tomography (CT) 
imaging is used for the conversion of Hounsfield unit (HU) values to relative electron density (in photon 
therapy) or stopping power ratio relative to water (in proton therapy). This information is needed for the 
computation of the dose to deliver to the patient (Chernak et al 1975). Magnetic resonance imaging (MRI) 
yields superior soft-tissue visualization allowing for a better visualization of the target and the assessment of 
organs at risk (OARs) motion and deformation without patient radiation burden (Lagendijk et al 2014). In the 
last few years, MRI-only RTP has been introduced into clinics (Edmund and Nyholm 2017, Tenhunen et al 
2018) promising to avoid systematic uncertainties arising from the CT-MR image registration and to decrease 
the patient exposure to ionizing radiation by skipping the planning-CT. Reducing both the registration 






































































uncertainties and the patient imaging dose is particularly important for pediatric patients for whom the radiation 
oncology community strives to minimize the risk of radiation-induced complications.  
Currently, the main challenge of performing MRI-only dose calculations is the estimation of tissue 
attenuation properties from the MR images. For this purpose, the commonly named pseudo-CT or synthetic-CT 
(sCT) images can be generated from the patient’s MR image to serve as surrogate for the dose calculations.  
Two recent review articles by Edmund and Nyholm (2017) and Johnstone et al (2018) provide a 
comprehensive overview of the currently available sCT generation methods.  These can be divided in four 
different approaches: bulk-density override, atlas-based, voxel-based and more recently introduced deep 
learning methods. Bulk-density override has been studied for over a decade with either manual or automatic 
contour segmentation (Lee et al 2003, Stanescu et al 2008). Although this technique provides a user-friendly 
method for sCT generation, it does not allow a straightforward creation of reference images for patient 
positioning verification during RTP (Johnstone et al (2018). For the atlas-based methods, the main goal is to 
create an MR to CT image atlas and convert the MRI intensity into HU values by registering the patient’s MRI 
to the atlas (Dowling et al 2012, Uh et al 2014, Dowling et al 2015, Guerreiro et al 2017). The main drawbacks 
of this method are the lack of adaptation to atypical anatomies and the strict requirements for imaging posture 
and settings. Voxel-based methods rely only on the MRI contrast, independently of the voxels location, for the 
generation of sCT images for different body parts and anatomies (Hsu et al 2013, Edmund et al 2014, Korhonen 
et al 2014, Jonsson et al 2015). Compared to the atlas-based approach, images generated by this method are 
more vulnerable to MRI artifacts (Sjolund et al 2015). More recently, novel techniques for sCT generation are 
being explored by deep learning methods. Han (2017) and Dinkla et al (2018) have presented fast sCT 
generation methods using convolutional neural network (CNN) and Maspero et al (2018) using a conditional 
generative adversarial network (cGAN). Despite providing acceptable dose calculation accuracy, none of these 
sCT generation approaches is reported to outperform the others (Edmund and Nyholm 2017, Johnstone et al 
2018). Moreover, a population-based study comparing CT- and sCT-based dose calculations should be initiated 
in order to establish acceptable dosimetric deviations from the planning-CT dose for clinically relevant dose 
volume histogram (DVH) parameters (Korsholm et al 2014). 
In the past few years using the mentioned techniques, sCT images have been generated for several body sites 
such as brain (Edmund et al 2014, Jonsson et al 2015, Koivula et al 2016, Dinkla et al 2018), head & neck (Hsu 
et al 2013, Sjolund et al 2015, Guerreiro et al 2017) and pelvis (Korhonen et al 2014, Koivula et al 2016, 
Guerreiro et al 2017, Maspero et al 2017, Maspero et al 2018) in adult patients. The purpose of this study was to 
develop a method enabling sCT generation for pediatric patients, which is one of the most challenging patient 
populations as a result of the highly individual anatomies among patients. To the author’s knowledge, the 
present work is the first generating sCTs with a large field of view (FOV), including the whole abdomen, for 
children diagnosed with abdominal cancer. The presented sCT generation method was based on an automatic 
atlas-based segmentation of tissue classes followed by a voxel-based MRI intensity to HU values conversion 
algorithm. The accuracy of performing dose calculations with the generated sCTs was assessed for both photon 
and proton irradiation modalities.  
2. Material and methods 
2.1. Patient and imaging characteristics 
 
After institutional review board approval (WAG/mb/17/008865), data from 30 consecutive patients treated at 
the Department of Radiotherapy of University Medical Center Utrecht (UMCU) between April 2015 and 
January 2018 were included in this study:  9 WT patients (mean age: 3, range: 2-4 years), undergoing flank 
irradiation, and 21 NBL patients (mean age: 4, range 2-7 years). For 9 out of 30 patients, the target was located 
on the upper part of the abdomen within the diaphragm border (Patupps), while for the remaining 21 patients the 
target was located on the lower part of the abdomen (Patlows).  





































































After chemotherapy and resection, all patients received radiotherapy to the primary tumor site. For treatment 
preparation, 4-dimensional CT (4D-CT) and T2-weighted (T2w-) MR images were acquired for each patient on 
the same day (≤ 45 min), in radiotherapy treatment position and using the same FOV which covered the whole 
abdomen of the patient: from the neck until the pelvis. Patients were fixated in a supine position in an 
individualized vacuum mattress (Bluebag, Elekta, Stockholm, Sweden) and imaging was performed with 
patients under general anesthesia. The 4D-CT images were acquired using a 16-, 40-, or 64- channel detector 
scanner (Brilliance, Philips Medical Systems, Best, The Netherlands). Respiratory trace measurements for 
pulmonary gating were obtained using a deformable rubber belt fixed to the patient's chest (Philips Bellow 
System, Philips Medical Systems, Best, The Netherlands). The planning-CT was obtained by taking the pixel-
by-pixel mean of the ten phases of the 4D-CT. Voxel dimensions ranged between 0.8 – 1.4 mm for both left-
right (LR) and anterior-posterior (AP) directions and between 2 - 3 mm for the cranio-caudal (CC) direction, 
depending on the patient. The T2w-MR images were acquired using a 1.5T Philips Achieva MR scanner 
(Philips Medical Systems, Best, The Netherlands) and a 3D turbo spin echo sequence without motion 
compensation strategies. Voxel dimensions ranged between 0.7 – 0.8 mm for both LR and CC directions and 
between 1 - 3 mm for the AP direction, depending on the patient. The specific sequence parameters for the T2w-
MR images were as follows: TE= 90 ms, TR= 454.4 ms, flip angle= 90 deg, BW= 570 Hz and acquisition 
duration= 249 s. 
 
2.2. sCT generation 
 
The proposed sCT method is an extension of the previously published dual-model technique, described in 
detail in Korhonen et al 2014, Koivula et al 2016 and Koivula et al 2017, combining an automatic atlas-based 
segmentation and a voxel-based MRI intensity to HU values conversion algorithm for bone and soft-tissue 
classes. Briefly, in the current sCT method auto-segmentation and conversion algorithms for the lungs were 
included in addition to bone and soft-tissue classes. For each patient, a single T2w-MR image was used for the 
sCT generation. A schematic representation of the adopted workflow is shown in figure 1 and all steps are 
described in more detail on the following sections. 
 







































































Figure 1. Schematic representation of the workflow used in this study. For the image acquisition (1), both 
planning-CT and T2w-MR images were acquired on the same day and in radiotherapy treatment position. The 
sCT generation method (2) is divided in two steps: The automatic atlas-based segmentation followed by the 
MRI intensity to HU values conversion for the bone, lungs and soft-tissue classes. For the atlas construction, 
image data of 24 out of 30 patients was used and divided into 3 groups according to the patient height. For each 
patient (N=30), a single T2w-MR image was used for the sCT generation. The final two steps consisted of the 
sCT image processing (3) and the image and dose evaluation (4). 






































































2.2.1. Automatic atlas-based segmentation 
 
Rigidly registered, based on  mutual information,  planning-CT and T2w-MR images were used for the atlas 
construction. A selection of patients (24/30) was divided into three groups based on their height: group 1 (86-95 
cm), group 2 (96-112 cm), and group 3 (113-124 cm), each group containing 8 patients. A separate atlas was 
created for each of the three groups by manually contouring bones and lungs volumes on the T2w-MR images. 
For the sCT generation, the automatic segmentation of bone and lungs volumes from MRI was made using a 
leave-one-out strategy for the 24 patients included in the atlas database. For the remaining 6 patients, bone and 
lungs were automatically segmented using one of the three generated atlases depending on the patient’s height. 
The commercial medical image processing software MIM (version 6.7, MIM Software, Inc., Cleveland, OH, 
USA) was used for the automatic atlas-based segmentation by creating a deformable registration based on 
mutual information between the patient’s MR and the MR images in the atlas. Manually contoured bone and 
lungs volumes from the patients in the atlas were combined and average volumes were obtained for each patient. 
Additionally, the soft-tissue was automatically segmented using a Boolean exclusion of the segmented bone and 
lungs volumes from the body contour defined on the MRI. On the planning-CT, tissue classes were 
automatically segmented by applying a threshold: bone (HU > 150), lungs (HU < -150) and soft-tissue (-150 < 
HU < 150). No manual adjustments of the MRI and planning-CT contours were done after auto-segmentation.  
 
2.2.2. Conversion algorithms for bone, lungs and soft-tissue 
 
Before performing the MRI intensity to HU values conversion, the MR images were 3D bias-field corrected 
(Tustison et al 2010) to enable a uniform intensity level across the patient body. In addition, the original MRI 
intensity values were scaled to a coherent base level, which corresponded to the median intensity level of the 
adipose tissue calculated from the MR images of the 24 patients included in the atlases (Koivula et al 2017). 
This workflow was previously shown to be robust for the  sCT generation using MR images from multiple MR 
scanners and with different intensity levels.  
The conversion from MRI intensity to HU values was done directly by using three different curves 
corresponding to each of the automatic segmented tissue classes (section 2.2.1): bone, lungs and soft-tissue. 
Conversion curves (figure 1) were constructed using the segmented CT and MRI volumes of the 24 patients 
included in the atlases. Furthermore, the three calculated conversion curves were used for the MRI intensity to 
HU values conversion for all 30 patients. 
For the bone and lungs conversion curves construction, the MRI intensity and corresponding CT HU values 
were matched using histogram points: histogram peak as the median value and the 5% cut-off value from the 
median as minimum and maximum values. For the bone, the HU values conversion was executed as inversely 
proportional to the MRI intensity values.  As a result, the low signal from cortical bone on the MRI was linked 
to high HU values (HU = 807) while the high signal from bone marrow on the MRI was linked to lower HU 
values (HU = -47). For the lungs, the MRI intensity to HU values correspondence was defined to be directly 
proportional.  Therefore, the low signal from alveonic-rich tissue on the MRI was represented by low HU values 
(HU = -783) while the high signal from lung capillaries on the MRI was represented by higher HU values (HU = 
-101). For both conversion curves, a step-wise function using twelve constant HU segments was used to 
estimate the values in between. For the soft-tissue conversion curve construction, MRI intensity values were 
collected using regions of interest inserted in the muscle, adipose tissue and fluids. Then, the MRI voxel values 
were converted into HU values in a three-part step-wise conversion relying on the known HU values of muscle 
(HU = 55), adipose tissue (HU = -105) and fluids (HU = 10). HU values between these three segments were 










































































2.2.3. sCT image processing 
 
For each patient, the sCT was re-sampled to the planning-CT dimensions. On the sCT, the body contour 
from the planning-CT was used instead of the body contour provided by the MRI. This was done to minimize 
uncertainties arising from set-up and time differences between the CT and MR imaging sessions. Thus, areas of 
the MRI outside the planning-CT body contour were manually labeled as -1000 HU and areas of the planning-
CT outside the MRI body contour were manually labeled as 0 HU. Furthermore, on the original sCTs the bowel 
gases were assigned automatically as muscle HU while no density override was performed on the planning-CT. 
To minimize the possible differences between the planning-CT and the original sCT doses arising from the 
bowel filling, a second set of sCTs was generated containing the air pockets extracted from the planning-CT 
(sCTair).   
 
2.3. Treatment planning characteristics 
 
For both patient groups, the gross tumor volume (GTV) consisted of the pre-operative tumor extension, 
including pathologic lymph nodes and residual disease if applicable. The clinical target volume (CTV) was 
created by expanding the GTV by 5 to 10 mm. To account for the breathing motion, assessed by using a 4D-CT 
and surgical clips as surrogates, an internal target volume (ITV) was individualized in each orthogonal direction 
for all patients.  
The sCT dosimetric accuracy was assessed for both volumetric modulated arc therapy (VMAT), used 
currently clinically at the Department of Radiotherapy of UMCU to treat these patients, and pencil beam 
scanning (PBS). For both VMAT and PBS plans, RTP was performed in RayStation treatment planning system 
(Raysearch, Stockholm, Sweden) using the planning-CT and a uniform dose grid of 3 mm. The VMAT plans 
consisted of a 6MV full-arc. Since the target volumes are mainly located in the posterior part of the abdomen, 
the PBS plans were based on two or three posterior irradiation fields to avoid the effect of bowel filling on the 
dose distributions. The center of the ITV was selected as the isocenter for both delivery techniques. The 
prescribed dose (PD) ranged from 14.4 to 36.0 Gy, depending on the patient case.   
Both VMAT and PBS plans were robust optimized on the ITV using a minimax optimization method 
(RaySearch Laboratories 2014, Fredriksson et al 2011) and a uniform 5 mm patient set-up uncertainty. For the 
PBS plans, robustness against range uncertainty was not accounted for to assess the dose differences in a setting 
more susceptible to density changes between the planning-CT and the generated sCTs. For the robust plan 
optimization, plans were optimized accounting for the nominal plan plus 6 different scenarios where the plan 
isocenter was shifted in fixed directions using the magnitude of the selected set-up uncertainty (RayStation 
Laboratories 2014, Frediksson et al 2011). For the plan robustness evaluation, dose distributions for different 
scenarios were computed using the same magnitude of the set-up uncertainty in 26 fixed directions. 
Additionally, the information from all 26 scenarios per technique was combined in a voxel-wise minimum 
evaluation dose (Vwmin) by calculating the minimal dose per voxel in all scenarios. Plans were considered robust 
if in the Vwmin 98% of the ITV received at least 95% of the PD (V95%>98%) (Korevaar et al 2017). To reduce 
the risk of asymmetric skeletal growth, a homogeneous dose was aimed for the vertebra volume adjacent to the 
ITV. To achieve that, the following constraint was implemented to the vertebra volume: V70-80% > 95-98%, 














































































2.4. sCT evaluation 
 
2.4.1. Image evaluation 
 
The imaging evaluation of the original sCTs was done by calculating the voxel-wise mean error (ME) and 
the mean absolute error (MAE) in terms of HU against the corresponding planning-CT. The ME and MAE were 
calculated in a Boolean intersect of the automatic planning-CT and MRI bone, lungs, and soft-tissue volumes 
(section 2.2.1) to minimize the unavoidable HU differences due to random air pockets, posture and/or lungs 
volume differences due to breathing motion between consecutive CT and MR imaging sessions. In addition, the 
Dice similarity coefficient (DSC) was calculated for the segmented bone and lungs volumes on the planning-CT 
and MR images.  
 
2.4.2. Dose evaluation 
 
To validate the dosimetric accuracy of the sCTs, dose re-calculations of the VMAT and PBS plans were 
performed on the generated sCTs (sCT and sCTair) and on a water bulk density sCT (sCTbulk). The relative dose 
differences between the planning-CT and sCTs doses were calculated for the following DVH metrics: ITV 
D98% , D50%, D2% and V95% , as well as OARs (kidneys, liver, spleen) mean dose (Dmean), D50%, D20% and D2%. 
Moreover, the dose distributions of the treatment plans re-calculated on all sCTs were compared to that on the 
planning-CT by means of different 3D global gamma criteria: (3%, 3 mm) and (2%, 2 mm), with a 90%, 50% 
and 10% dose threshold.  
3. Results 
 
3.1. Image evaluation 
 
Coronal and sagittal slices of the planning-CT, T2w-MRI and the original sCT are shown in figure 2 for one 
Patupp (a-c) and one Patlow (d-f). Automatic atlas-based segmentation time was approximately 3 minutes and MRI 
intensity to HU values conversion time was approximately 15 seconds per patient using a standard octa-core 
desktop computer with a 16 GB of RAM. Despite the fact that images were acquired on the same day and under 
radiotherapy treatment position, the planning-CT and MR images demonstrate substantial inter-scan differences 
regarding either the size of the patient, the lungs volume and the presence of air pockets (figure 2, figure 3). 
Nevertheless, the original sCTs reproduced the appearance of the different tissue classes. The computed DSC 
was 0.90 ± 0.04 (min 0.82; max 0.98) and 0.74 ± 0.08 (min 0.54; max 0.87) for the bone and lungs volumes.  
The calculated ME was 11 ± 113 HU (min -170 HU; max 207 HU) in bone, -3 ± 65 HU (min -165 HU; max 163 
HU) in lungs and 21 ± 11 HU (min 0 HU; max 55 HU) in soft-tissue. The calculated MAE was 212 ± 40 HU 
(min 154 HU; max 291 HU) in bone, 125 ± 24 HU (min 86 HU; max 198 HU) in lungs and 53 ± 7 HU (min 42 
HU; max 74 HU) in soft-tissue. The largest HU discrepancies between the planning-CT and the original sCT 
images were seen in the lungs and in the ribs (figure 3, (d)).  
 







































































Figure 2. Coronal (top) and sagittal (bottom) slices of the planning-CT (a,d), T2w-MRI (b,e) and the original 
sCT (c,f) for one Patupp (top) and one Patlow (bottom). The ITV is denoted in white.  
 
Figure 3. Transversal slices of the planning-CT (a), T2w-MRI (b) and the original sCT (c) for one example 
patient. Body contours extracted from the planning-CT and MR images are presented in pink and green, 
respectively. The automatic atlas-based MRI contours for the bone and lungs are represented in red and yellow, 
respectively. HU differences between the planning-CT and the original sCT images are represented in (d).  
 






































































3.2. Dose evaluation 
 
The relative dose differences of clinically relevant DVH parameters between the planning-CT and all sCT 
doses are illustrated using box-and-whisker plots in figure 4 for the ITV and in figure 5 for the OARs.  
For the ITV, mean V95% deviations to the planning-CT doses were 0.5 ± 1.4%  (min 0.0%; max 5.0%) and 
0.0 ± 0.0% (min 0.0%; max 0.1%) for the VMAT dose distributions re-calculated on the original sCTs and 
sCTairs, respectively. For the PBS dose distributions, mean V95% deviations were 0.0 ± 0.0% (min -0.1%; max 
0.1%) and 0.0 ± 0.0% (min -0.1%; max 0.0%) for the original sCTs and sCTairs, respectively. Large dosimetric 
differences were observed between the planning-CT and the original sCT for the VMAT dose distributions 
(figure 4). The ITV coverage (V95%>99%) was not met for 3 patients due to the presence of large air pockets in 
the proximity of the ITV on the planning-CT and not on the sCT (figure 6). When inserting the air pockets from 
the planning-CT on the sCTair, the ITV dosimetric differences were considerably reduced (figure 4, figure 6). 
Given the use of posterior irradiation fields in the PBS plans, similar results were seen for the plans re-
calculated on both sCTs and sCTairs (figure 4, figure 6).  
For the OAR, the Dmean differences ranged between  (min -0.6%; max 1.2%) and (min -0.7%; max 0.1%) for 
the VMAT dose distributions re-calculated on the original sCTs and sCTairs, respectively. For the PBS dose 
distributions, larger individual differences between the planning-CT and sCT were observed (figure 5). The 
range of Dmean differences was (min -2.0%; max 2.6%) and (min -2.6%; max 2.5%) for the original sCT and 
sCTair, respectively. Furthermore, an increase up to 4% on the OAR D2% was calculated for both delivery 
techniques for the Patupps in comparison to the Patlows (Table 2). This was due to the large inter-scan differences 
seen regarding the lungs volume definition between the planning-CT and MR images (figure 3).  
The gamma pass-rates obtained between the planning-CT and all sCT doses are given in table 1. Mean 
gamma pass-rates were above 87% for the generated sCTs independently of the considered gamma criteria. 
Focusing on the high-dose region (with a 90% dose cut-off), mean gamma pass-rates above 92% were achieved 
for both irradiation techniques. For the VMAT plans re-calculated on the original sCTs, the gamma pass-rates 
were lower than for the sCTairs due to the difference of air volumes on the planning-CT and sCT, as mentioned 
previously. When inserting the air pockets from the planning-CT on the sCTair, the gamma pass-rates were 
considerably increased. For the PBS plans, similar gamma pass-rates were obtained between the sCTs and 
sCTairs. Moreover, large differences on the gamma pass-rates were denoted for the original sCTs between the 
Patupps and Patlows (Table 2). A decrease on the mean gamma pass-rates of 22 percentage points (pp) and 7pp 
was observed for the Patupps in comparison to Patlows for the VMAT and PBS dose distributions, respectively. 
Moreover, the dosimetric accuracy of the sCTbulks was reduced in comparison to performing the dose re-
calculations on the generated sCTs, especially for the PBS dose distributions. For the VMAT dose distributions, 
mean DVH differences to the planning-CT doses were up to 0.8% (max 5.0%) vs. 0.6% (max 1.6%) vs. 0.7% 
(max 3.1%) for the sCT, sCTair and sCTbulk doses, respectively. For the PBS dose distributions, mean DVH 
differences were up to 0.5% (max 5.4%) vs. 0.7% (max 5.3%) vs. 4% (max 19.8%) for the sCT, sCTair and 
sCTbulk doses, respectively. Moreover, mean gamma pass-rates for the sCTbulks were considerably lower than for 
the generated sCTs, especially for the PBS plans (table 1, < 89%; min 53%). An increase on the mean gamma 
pass-rates up to 6pp and 15pp was achieved when using the generated sCTs in comparison to the sCTbulks for the 












































































Table 1. Percentage of gamma pass-rates (%) for the comparison of planning-CT and sCT doses using different 
gamma criteria (mm_%) and dose thresholds (10%, 50% and 90%). Abbreviations: sd= standard deviation. 
   
Gamma Pass-rate (CT & sCT) (%) 
   
10% 50% 90% 
Criteria Dose  Mean + sd Range Mean + sd Range Mean + sd Range 
3mm_3% 
VMAT 
sCT 99.3 ± 0.7 [97.2 - 99.9] 97.6 ± 3.3 [86.0 - 99.9] 97.6 ± 6.1 [74.8 - 100] 
sCTair 99.5 ± 0.4 [98.8 - 99.9] 98.8 ± 1.2 [95.3 - 99.9] 99.6 ± 1.7 [91.6 - 100] 
sCTbulk 99.1 ± 0.9 [96.2 - 99.8] 97.3 ± 2.9 [88.0 - 99.9] 98.0 ± 4.4 [84.2 - 100] 
PBS 
sCT 91.4 ± 4.3 [79.0 - 99.5] 92.9 ± 4.3 [76.7 - 99.4] 97.7 ± 3.9 [79.4 - 100] 
sCTair 92.1 ± 3.3 [84.0 - 99.8] 92.7 ± 4.1 [76.6 - 99.4] 97.5 ± 4.2 [79.3 - 100] 
sCTbulk 81.6 ± 4.0 [70.8 - 89.8] 81.4 ± 5.4 [64.6 - 88.5] 89.2 ± 7.8 [64.4 - 99.0] 
2mm_2% 
VMAT 
sCT 97.7 ± 2.2 [92.8 - 99.7] 93.6 ± 7.1 [73.1 - 99.4] 92.4 ± 13.5 [46.8 - 100] 
sCTair 98.5 ± 1.6 [93.5 - 99.7] 97.1 ± 2.5 [89.5 - 99.3] 98.9 ± 3.4 [83.2 - 100] 
sCTbulk 97.3 ± 2.3 [92.5 - 99.5] 93.2 ± 6.7 [76.5 - 99.7] 93.1 ± 11.2 [60.1 - 100] 
PBS 
sCT 87.1 ± 5.4 [72.3 - 98.6] 89.2 ± 5.3 [71.5 - 97.8] 95.2 ± 5.2 [73.4 - 100] 
sCTair 88.1 ± 4.4 [73.8 - 99.1] 89.2 ± 4.9 [71.4 - 97.9] 95.1 ± 5.6 [73.1 - 100] 
sCTbulk 75.1 ± 4.6 [63.6 - 82.1] 74.5 ± 6.5 [57.4 - 83.6] 81.1 ± 10.4 [53.2 - 95.7] 
 
Table 2. Percentage of OARs D2% differences and gamma pass-rates (%) for the comparison of planning-CT 









Patupps (N=9) Patlows (N=21) Patupps (N=9) Patlow s (N=21) 
DVH Structure 
 
Mean Range Mean Range Mean Range Mean Range 
D2% 
Kidneys 
sCT 0.6 [-0.8; 1.7] 0.2  [-0.8; 1.7] 0.7 [-1.2; 5.4] 0.3  [-1.4; 2.8] 
sCTair -0.6 [-0.9; 0.1] -0.5 [-1.3; 0.0] 0.7 [-1.2; 5.3] 0.3 [-1.4; 2.8] 
Liver 
sCT -0.1 [-0.7; 0.3] -0.1 [-0.7; 0.4] 0.3  [-4.1; 4.0] 0.0  [-2.6; 0.4] 
sCTair -0.1 [-0.7; 0.2] -0.4 [-0.7; 0.1] 0.0 [-4.1; 4.0] 0.1 [-2.6; 0.5] 
Spleen 
sCT 0.9 [-0.1; 3.4] -0.1 [-0.9; 0.6] 0.6 [-0.3; 3.9] -0.1 [-2.3; 1.7] 
sCTair -0.2 [-0.9; 1.1] -0.4 [-1.0; 0.0] 0.6  [-0.3; 3.9] -0.1 [-2.3; 1.7] 
Gamma Threshold 
 




sCT 94.8 [92.8; 98.9] 98.7 [95.9; 99.7] 82.3 [72.3;88.5] 88.6 [83.7; 98.6] 
sCTair 96.4 [93.5; 99.5] 98.9 [96.3; 99.7] 83.3 [73.8; 88.5] 89.2 [84.6; 99.1] 
50% 
sCT 85.2 [73.1; 95.5] 96.5 [86.5; 99.4] 84.5 [71.5; 92.7] 90.8 [86.9; 97.8] 
sCTair 94.3 [89.5; 97.3] 97.7 [95.1; 99.3] 84.2 [71.4; 89.3] 90.3 [86.2; 97.9] 
90% 
sCT 75.4 [46.8; 99.0] 97.3 [83.1; 100] 90.1 [73.4; 97.4] 96.5 [89.7; 100] 
sCTair 95.6 [83.2; 100] 99.4 [94.6; 100] 89.4 [73.1; 96.2] 96.4 [87.9; 100] 
 







































































Figure 4. Box-and-whiskers plots of the ITV DVH parameters differences between the planning-CT and sCT 
doses for the VMAT (1-3) and PBS (4-6) plans re-calculated on the original sCT (1,4), sCTair (2,5) and sCTbulk 
(3,6). Values are presented as a percentage of the respective PD. 







































































Figure 5. Box-and-whiskers plots of the kidneys (a), liver (b) and spleen (c) DVH dosimetric differences at a 
given relative volume between the planning-CT and the original sCT (1,4), sCTair (2,5) and sCTbulk (3,6) for both 
VMAT (1-3) and PBS (4-6) dose distributions. Values are presented as a percentage of the respective PD. 







































































Figure 6. VMAT (top row) and PBS (bottom row) dose maps for doses re-calculated on the planning-CT (a,e), 
sCT (b,f), sCTair (c,g) and sCTbulk (d,h) for one Patlow. The ITV contour is represented in white. The PD is 21.6 
Gy and the 95%PD isoline is shown in red. 
 
Figure 7. VMAT (top row) and PBS (bottom row) dose maps for doses re-calculated on the planning-CT (a,e), 
sCT (b,f), sCTair (c,g) and sCTbulk (d,h) for one Patupp. The ITV contour is represented in white. The PD is 21.6 
Gy and the 95%PD isoline is shown in red. 
4. Discussion 
In this study, a method able to generate sCTs for the whole abdomen of pediatric patients using an automatic 
atlas-based segmentation combined with a triple-model technique for MRI intensity to HU values conversion 
was presented. To the author’s knowledge, the present study is the first evaluating the feasibility of generating 
sCTs for children aged from 2 to 7 years old and treated for abdominal cancer, which is one of the most 
challenging patient populations as a result of the highly individual anatomies among patients. Results show that 
MRI-only photon and proton dose calculations on the generated sCTs were feasible. 
The quantitative comparison of CT and sCT images is still under discourse. Edmund and Nyholm (2017) and 
Johnstone et al (2018) underline the importance of developing common standards for the quantification of the 
sCT accuracy for further improvements in this field. In this study, the sCT image accuracy was evaluated by 
using ME and MAE metrics. The mean ME was limited (< 21 HU) for all tissue classes, indicating a good fit of 
the sCT method in general. Nevertheless, there was a considerable variation between patients predominantly for 
the bone. For this volume, a mean MAE of 212 HU was calculated, even though the reported mean ME was 11 






































































HU. This can be explained by the intensity inhomogeneity detected on the MR images mostly caused by the 
large imaging volume compared to other body parts such as the pelvic region. Previous studies on the prostate 
have reported MAE differences in the bone of 97 HU for the dual-model technique (Koivula et al 2016) and 134 
HU for the atlas-based method (Dowling et al 2015). Additionally, high HU differences between the planning-
CT and sCT images were detected in the ribs region and in the lungs. HU differences in the ribs can be 
explained by their small volume, by their poor visibility on the MRI and by their position variability among all 
patients. Moreover, HU differences in the lungs volume can be justified by the acquisition of both planning-CT 
and MR images during different breathing stages. Motion compensation strategies were used during the 
planning-CT acquisition, by obtaining a 4D scan of a full breathing cycle, but not during the MRI acquisition. 
Smaller HU differences between the lungs volumes might potentially be achieved if matching breathing 
anatomies between MR and CT images had been evaluated. In this study, the clinical MR images were used as 
acquiring MRI sequences that are not included in the standard practice protocol is more difficult for children due 
to the stringent ethical regulations associated this patient group. Nevertheless, no significant motion artifacts 
were detected in the present MRI dataset and lungs segmentation was performed directly on the MR images 
(figure 3). With more focus on the MRI intensity variation and fine tuning of MRI sequences, improved results 
could potentially be achieved for both atlas-based segmentation and intensity conversion models.  
Besides the sCT imaging comparison, another requirement for the MRI-only workflow is the practical sCT 
method implementation: conversion speed, robustness, usability and amount of preliminary data needed for the 
atlas creation or network teaching– for which quantitative metrics maybe even more difficult to establish. 
Regarding the conversion speed, the most time-consuming task during this sCT generation method is the 
automatic atlas-based segmentation of bone and lungs. However, the sCT generation time is considerably fast 
(approximately 3 minutes taken fully by the automatic atlas-based segmentation step) and comparable to 
previous publications. The review by Johnstone et al (2018) presented generation times mainly under 5 minutes 
for voxel-wise methods and a larger variation from a couple of minutes to over an hour for atlas-based methods. 
Novel techniques based on deep learning can however provide sCT generation in the time scale of seconds 
(Maspero et al 2018).  Concerning the method’s usability, the sCT generation workflow was designed to be 
highly accessible and easily adopted by most clinical users. However, the method’s commissioning presents 
some limitations as every user needs to validate a suitable segmentation for the bone and lungs. Regarding the 
amount of preliminary data needed, a considerably feasible number of patients (N=24) was used for the atlas 
construction in this study. Nevertheless, the exact number of patients needed to assure an optimal ratio between 
automatic atlas-based segmentation time and accuracy still remains uncertain.  
The sCT dosimetric accuracy was evaluated for both photon and proton irradiation techniques. Plans were 
optimized on the planning-CT and re-calculated on the sCT images. No optimization of the plans on the sCT 
and re-calculation of the same on the planning-CT was performed. This methodology was chosen as in literature 
it was previously shown that the CT-sCT dose comparison was invariant with respect to the optimization 
method used (Koivula et al 2016). Results show that MRI-only photon and proton dose calculations were 
feasible when using the generated sCTs for pediatric patients with abdominal tumors. Mean DVH differences on 
the ITV between the planning-CT and the original sCT doses were smaller than 0.8% for both delivery 
techniques. Individual differences were up to 5% and 0.7% for the VMAT and PBS dose distributions, 
respectively. For the VMAT dose distributions, the ITV coverage was not met for 3 patients due to differences 
in the existence of air volumes between the planning-CT and the original sCT (figure 3). The proposed sCT 
generation method performed automatically a muscle HU assignment to all air cavities seen on the MRI. After 
delineating the air from the planning-CT and using this contour for further dose calculations on the sCTair, the 
target coverage was restored. For photon therapy, discrepancies between planned and delivered doses generated 
by the presence of random air pockets in the vicinity of the ITV need to be avoided. As a result, planning 
strategies such as performing density override on the CT image during planning or using online daily re-
planning in an MRI-guided photon workflow (Kontaxis et al 2015a, Kontaxis et al 2015b) might need to be 
implemented. For an MRI-guided workflow to be able to fully reproduce the patient’s daily anatomy, an 






































































automatic air cavities delineation tool is essential for the investigated sCT generation method. This is 
particularly difficult to implement while using standard MRI sequences as both cortical bone and air have no 
signal on MRI. However, in literature (Johansson et al 2011, Edmund et al 2014) it has been shown that 
ultrashort echo time (UTE) pulse sequences can improve the contrast between bone and the surrounding air and 
soft-tissue enabling a rough separation between these tissues classes. For PBS dose distributions, uncertainties 
related to the presence of random air pockets can be avoided by using posterior-oblique irradiation fields. When 
using this beam configuration, results show that dose differences to the planning-CT dose were similar for both 
original sCT and sCTair.  
Mean gamma pass-rates for the generated sCTs doses ranged from 92-100% and 87-98% for VMAT and 
PBS dose distributions, respectively. Gamma pass-rates results for the PBS dose distributions were lower in 
comparison with studies in literature evaluating the sCT proton dose calculation accuracy for patients with 
prostate cancer (Koivula et al 2016, Maspero et al 2017). For a 2mm_2% criterion and 10% dose threshold, 
Koivula et al (2016) and Maspero et al (2017) reported a mean gamma pass-rate of 98%, in comparison with 
87-88% in this study. Two main reasons were responsible for this lower PBS gamma pass-rate: (1) the large 
target size (mean 100cc) and (2) the use of  non-robust dose distributions to range uncertainty. For the patients 
included in this study, the ITV was extended cranio-caudally throughout the whole abdomen. As a result, sCT 
dose re-calculations were subject to larger HU discrepancies detected between the planning-CT and MR images. 
Despite both planning-CT and MR images were acquired on the same day and under radiotherapy treatment 
position, the images demonstrated substantial inter-scan differences mostly regarding the lungs volume (mean 
DSC ~ 0.7). As a result, larger relative dose deviations between the planning-CT and sCT doses were seen, 
especially for the Patupps (figure 7). For the PBS dose distributions re-calculated on the generated sCTs, a 
decrease of 7pp on the mean gamma pass-rates was calculated for the Patupps in comparison to Patlows. 
Moreover, PBS plans non-robust to range uncertainty were used in this study to assess the differences between 
the planning-CT and sCT doses in a setting more susceptible to density changes. However, protons can be more 
sensitive to uncertainties in CT densities and patient anatomy than common photons (Lomax 1999). Robust 
planning is currently used in proton therapy to guarantee that the target coverage is maintained throughout the 
treatment by mitigating the effect of both range and set-up uncertainties. Thus, proton dose calculation accuracy 
might be further improved when using a robust planning technique against both set-up and range uncertainties. 
Furthermore, doses were re-calculated on an homogeneous water equivalent density sCT to evaluate the 
added value of using the generated sCTs for the dose calculations against using the sCTbulks. Dosimetric 
accuracy was reduced when using the sCTbulks for the dose re-calculations, especially for the PBS dose 
distributions with individual dose differences to the planning-CT dose up to 20%. 
During RTP, another aspect that should be taken into account is the MRI geometric distortions and 
consequently the geometric accuracy of the sCTs. Gradient non-linearity distortions are the most dominant 
source of MRI distortions and have been shown to be more noticeable away from the scanner isocenter (Wang 
et al 2004, Baldwin et al 2007). Nevertheless, Tijssen et al (2017) showed that geometric distortions are only 
limited to 0.9 mm for a spherical volume with similar dimensions to a children’s abdomen (30 cm diameter). In 
this study, the patients’ external contours between the planning-CT and sCT images were matched to reduce the 
influence of inter-scan differences due to patient set-up and anatomic differences on the dosimetric results (Prior 
et al 2016, Gustafsson et al 2017, Persson et al 2017). Analyzing the geometric accuracy of the generated sCTs 
was out of the scope of this paper, however the authors are aware that performing a match of the external 
contours between images might reduce the dosimetric differences seen. Future work will focus on evaluating the 
sCT geometric fidelity and patient position verification while using the generated sCTs for this patient group.  
Similarly to the previously published dual-model technique (Korhonen et al 2014, Koivula et al 2016, 
Koivula et al 2017), the sCT generation method is robust in the absence of major artifacts and to general 
changes in MRI intensity levels and is suitable to be used for images acquired with different MR platforms and 
vendors. Improvement of the triple-model in comparison to the dual-model technique is the expanded usability 
when adding lung tissue for the sCT conversion model. In contrast, it is more sensitive to variations in the MRI 





































































intensity homogeneity as there are three distinct conversion curves for which all the MRI intensities have to 
correspond accordingly. The sCT dosimetric accuracy for targets directly located in the lungs was not tested in 
this study. Nevertheless, results were presented for both Patupps and Patlows. Despite that a feasible atlas-based 
segmentation of the lungs was possible when using T2w-MR images, a decrease in the dosimetric accuracy for 
Patupps in comparison to Patlows was seen. For the Patupps, these dosimetric differences might potentially be 
reduced if matching breathing anatomies between CT and MR images had been used. Future work should focus 
on improving the MRI acquisition by using motion mitigation techniques and on the development of dedicated 
MRI sequences for the sCT generation.  
Nevertheless, the results presented in this study are a promising step for the future clinical implementation of 
an MRI-only radiotherapy workflow to treat children with abdominal tumors. The employed method is able to 
generate sCTs with a large FOV, including the whole abdomen of the patient, which is essential for RTP. 
Accurate MRI-only photon dose calculations were achieved with the generated sCTs. However, the correct 
representation of air pockets in the bowel was found crucial. For MRI-only proton dose calculations, future 
research should focus in reducing anatomic differences between the CT and the generated sCTs and using 
robustness against range uncertainties during planning for a more realistic dose comparison. 
 
5. Conclusions 
In the present study, the feasibility of generating sCTs for children using standard T2w-MR images with a 
large FOV, including the whole abdomen of the patient, was evaluated. The proposed sCT generation method 
combined an automatic atlas-based segmentation with a triple-model technique for MRI intensity to HU values 
conversion for bone, lungs and soft-tissue classes. Results show that MRI-only photon and proton dose 
calculations for pediatric patients with abdominal tumors were feasible. Clinical implementation of the proposed 
method will, however, require further investigations on improving the MRI acquisition, evaluating the sCT 
geometric fidelity and in using robust treatment planning strategies.  
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